Lorenzo Falchi - Dissemin

All papers authored by Lorenzo Falchi

This paper was not found in any repository, but could be made available legally by the author.

2022 Marina Moretti

, Anna Marina Liberati, Luigi Rigacci

, Benedetta Puccini, Alessandro Pulsoni

, Guido Gini, Piero Galieni, Alberto Fabbri

, Maria Cantonetti, Vincenzo Pavone, Silvia Bolis, Barbara Botto, Daniela Renzi, Lorenzo Falchi

Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience

Upload

2021 Lorenzo Falchi

, Filiz Sen

18 FDG‐avid cholesterol granuloma mimicking residual aggressive lymphoma after chemotherapy

Upload

Distributing this paper is prohibited by the publisher

Eric Mou, Lorenzo Falchi

, Vandana Sundaram, Jeremy S. Abramson, Ronald Balassanian

, Sara Beygi, Megan J. Fitzpatrick, Annabel Kate Frank, Srishti Gupta, Oscar Lin, Joshua R. Reed, Steven R. Long, Amy Ly, Joshua R. Menke, Daniel R. Reed and 9 other authors

Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2020 Lorenzo Falchi

, Helen Ma

, Sandra Klein, Jennifer K. Lue, Francesca Montanari, Enrica Marchi, Changchun Deng, Hye A. Kim, Aishling M. Rada, Alice T. Jacob, Cristina Kinahan, Mark M. Francescone, Craig R. Soderquist

, David C. Park, Govind Bhagat

and 6 other authors

Combined Oral 5-Azacytidine and Romidepsin are Highly Effective in Patients with PTCL: A Multicenter Phase 2 Study

Upload

Candida Vitale

, Lorenzo Falchi

, Maria Ciccone, Jan Burger, Naveen Pemmaraju, Gautam Borthakur, William G. Wierda, Michael J. Keating, Alessandra Ferrajoli

Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies

Upload

This paper is made freely available by the publisher.

2019 Helen Ma

, Bin Cheng, Lorenzo Falchi

, Enrica Marchi, Ahmed Sawas, Govind Bhagat, Owen A. O'Connor

Survival benefit in patients with peripheral T‐cell lymphomas after treatments with novel therapies and clinical trials

Download from api.wiley.com

Owen A. O’Connor, Lorenzo Falchi

, Jennifer K. Lue, Enrica Marchi, Cristina Kinahan, Ahmed Sawas, Changchun Deng, Francesca Montanari, Jennifer E. Amengual, Hye A. Kim, Aishling M. Rada, Karen Khan, Alice T. Jacob, Michelle Malanga, Mark M. Francescone and 10 other authors

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

Upload

2018 Lorenzo Falchi

, Srdan Verstovsek

Kit Mutations

Upload

Lorenzo Falchi

, Alessandra Ferrajoli, Ira Jacobs, Pilar Nava-Parada

An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma

Download from doi.org

Owen A. O'Connor, Jennifer K. Lue, Ahmed Sawas, Jennifer E. Amengual, Changchun Deng, Matko Kalac, Lorenzo Falchi

, Enrica Marchi, Ithamar Turenne, Renee Lichtenstein, Celeste Rojas, Mark Francescone, Lawrence Schwartz, Bin Cheng, Kerry J. Savage and 7 other authors

Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial

Upload

L. Falchi

, S. Verstovsek

Polycythemia vera and essential thrombocythemia

Upload

2017 Jennifer E. Amengual